EVALUATING THE ROLE OF CD4-LYMPHOCYTE COUNTS AS SURROGATE END-POINTS IN HUMAN-IMMUNODEFICIENCY-VIRUS CLINICAL-TRIALS

被引：0

作者：

LIN, DY ^{[1
]}

FISCHL, MA ^{[1
]}

SCHOERFELD, DA ^{[1
]}

机构：

[1] UNIV NAIROBI,DEPT MED MICROBIOL,NAIROBI,KENYA

来源：

STATISTICS IN MEDICINE | 1994年 / 13卷 / 18期

关键词：

D O I：

10.1002/sim.4780131810

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1895 / 1896

页数：2

共 50 条

[1] EVALUATING THE ROLE OF CD4-LYMPHOCYTE COUNTS AS SURROGATE END-POINTS IN HUMAN-IMMUNODEFICIENCY-VIRUS CLINICAL-TRIALS
LIN, DY
FISCHL, MA
SCHOENFELD, DA
[J]. STATISTICS IN MEDICINE, 1993, 12 (09) : 835 - 842
[2] EVALUATING THE ROLE OF CD4-LYMPHOCYTE COUNTS AS SURROGATE END-POINTS IN HUMAN-IMMUNODEFICIENCY-VIRUS CLINICAL-TRIALS - REPLY
LIN, DY
[J]. STATISTICS IN MEDICINE, 1994, 13 (18) : 1896 - 1896
[3] INCOMPLETE MULTIRESPONSE DESIGNS AND SURROGATE END-POINTS IN CLINICAL-TRIALS
SEN, PK
[J]. JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 1994, 42 (1-2) : 161 - 186
[4] SURROGATE END-POINTS IN CLINICAL-TRIALS - GETTING CLOSER TO IDENTIFYING MARKERS FOR SURVIVAL IN AIDS
ELLENBERG, SS
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1991, 302 (6768): : 63 - 64
[5] SURROGATE AND AUXILIARY END-POINTS IN CLINICAL-TRIALS, WITH POTENTIAL APPLICATIONS IN CANCER AND AIDS RESEARCH
FLEMING, TR
PRENTICE, RL
PEPE, MS
GLIDDEN, D
[J]. STATISTICS IN MEDICINE, 1994, 13 (09) : 955 - 968
[6] THE RELATIONSHIP OF TOTAL LYMPHOCYTE COUNT TO LYMPHOCYTE-CD4 COUNTS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
FOURNIER, AM
SOSENKO, JM
[J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 304 (02): : 79 - 82
[7] THE RELATIONSHIP OF TOTAL LYMPHOCYTE COUNT TO CD4 LYMPHOCYTE COUNTS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
FOURNIER, AM
SOSENKO, JM
[J]. CLINICAL RESEARCH, 1991, 39 (02): : A574 - A574
[8] ANALYZING SURVIVAL-DATA IN CONJUNCTION WITH TIME-DEPENDENT SURROGATE END-POINTS IN CLINICAL-TRIALS
TUDOR, GE
MORGAN, TM
[J]. COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1995, 24 (09) : 2293 - 2313
[9] CHEMOPREVENTION OF BREAST-CANCER - SURROGATE END-POINTS AND AGENTS IN SHORT-TERM CLINICAL-TRIALS - FOREWORD
不详
[J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 1 - 1
[10] POTENTIAL CLINICAL IMPLICATIONS OF INTERLABORATORY VARIABILITY IN CD4(+) T-LYMPHOCYTE COUNTS OF PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
SAX, PE
BOSWELL, SL
WHITEGUTHRO, M
HIRSCH, MS
[J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) : 1121 - 1125

← 1 2 3 4 5 →